The ubi1 Antibody (clone Ubi-1) is a mouse-derived monoclonal immunoglobulin G (IgG) that recognizes both free and conjugated ubiquitin molecules. Ubiquitin is an 8.5 kDa protein critical for marking cellular proteins for proteasomal degradation via polyubiquitin chain formation . This antibody exhibits preferential binding to polyubiquitinated targets over monoubiquitinated or free ubiquitin, making it valuable for studying protein turnover pathways .
Immunogen: Purified bovine erythrocyte ubiquitin cross-linked to keyhole limpet hemocyanin (KLH) .
Species Reactivity: Validated in humans, mice, rats, Drosophila, plants, and zebrafish .
Western Blot: Pre-treat lysates with 10 mM N-ethylmaleimide to preserve ubiquitination .
IHC-Paraffin: Requires citrate-based antigen retrieval for optimal signal .
In Saccharomyces cerevisiae, ubiquitin fused to ribosomal proteins (eL40 and eS31) facilitates their proper folding and integration into ribosomes .
Deletion of ubiquitin from the Ubi1 precursor causes severe growth defects, rescued only by ubiquitin or its homolog Smt3 .
Neurodegeneration: Labels pathological aggregates in Alzheimer’s neurofibrillary tangles and Lewy bodies .
Cancer: Detects aberrant ubiquitination in BRAF-mutant tumors, suggesting therapeutic targets .
KEGG: spo:SPAC11G7.04
STRING: 4896.SPAC1805.12c.1
Ubi-1 is a mouse monoclonal antibody specific to ubiquitin that particularly recognizes the human gene UBB (Polyubiquitin-B) . The epitope for this antibody is located in the peptide IQDKEGIPPDQQRLIFAGKQ, corresponding to amino acids 30-49 of bovine Ubiquitin. The central 10 amino acid segment, GIPPDQQRLI, is likely the most significant component of this antibody's epitope . This strategic epitope positioning allows the antibody to interact with ubiquitin in various molecular contexts, though with preferential binding to polyubiquitin chains over monoubiquitinated molecules or free ubiquitin .
The Ubi-1 antibody has been validated for multiple research applications including:
Western blot (WB) at dilutions of 1:1,000-1:2,000
Immunohistochemistry on paraffin-embedded sections (IHC-p)
Immunofluorescence (IF) at dilutions of approximately 1:2,000
Immunocytochemistry (ICC)
Enzyme-linked immunosorbent assay (ELISA)
For optimal results in Western blotting applications, researchers should note that dilution factors may need adjustment based on detection method sensitivity and protein expression levels.
Ubi-1 antibody demonstrates broad cross-species reactivity, which is consistent with the high conservation of ubiquitin across evolutionary lineages. Confirmed reactivity includes:
Mammals: Human, Mouse, Rat, Monkey, Horse, Bovine, Porcine
Birds: Chicken
Fish: Danio (zebrafish)
This extensive cross-reactivity makes Ubi-1 a versatile tool for comparative studies across different model organisms.
For maximum preservation of antibody functionality, Ubi-1 antibody should be shipped at 4°C. Upon receipt, researchers should aliquot the antibody to minimize freeze-thaw cycles and store at -20°C for long-term preservation . The antibody is typically supplied in Phosphate Buffered Saline with 50% Glycerol and 5mM Sodium Azide, which helps maintain stability during storage. It is critical to avoid repeated freeze-thaw cycles as these can lead to protein denaturation and subsequent loss of antibody activity and specificity.
For optimal Western blot results with Ubi-1 antibody, researchers should consider the following protocol guidelines:
Use standard SDS-PAGE separation for protein samples
Transfer proteins to a membrane using standard protocols
Block membranes in 5% non-fat milk in TBS-T for approximately 1 hour at room temperature
Dilute Ubi-1 antibody to 1:1,000-1:2,000 in 5% BSA in TBS-T
Incubate membranes with diluted primary antibody overnight at 4°C
Wash membranes with TBS-T (3-5 washes, 5 minutes each)
Proceed with appropriate secondary antibody incubation and detection
Unlike some other ubiquitin antibodies (such as VU-1), standard membrane preparation is sufficient for Ubi-1, without requiring glutaraldehyde pretreatment of transfer membranes .
When compared to other ubiquitin antibodies, Ubi-1 shows distinct binding preferences:
Ubi-1 recognizes polyubiquitin chains more strongly than monoubiquitinated molecules or free ubiquitin
It specifically recognizes ubiquitinated cytoplasmic proteins
In comparative studies with other ubiquitin antibodies (like VU-1, P4d1, 1b4, 6C1, FK1, and FK2), each antibody shows different affinities for various ubiquitin chain types and lengths
The VU-1 antibody has been documented as the "gold standard" for binding all types of poly-ubiquitin chains with high affinity and specificity . Researchers should select the appropriate antibody based on their specific experimental needs and the ubiquitin structures they aim to detect.
Sample preparation significantly impacts Ubi-1 antibody detection efficiency. While standard protocols work well with Ubi-1, researchers should consider these factors:
Preservation of ubiquitinated proteins during lysis by including deubiquitinase inhibitors (like N-ethylmaleimide or PR-619)
Selection of appropriate lysis buffers that maintain protein conformation while effectively extracting ubiquitinated proteins
Controlling temperature during extraction to prevent enzymatic degradation
Optimizing protein loading amounts - typically 30 ng of poly-ubiquitins per lane on SDS-PAGE provides good signal with Ubi-1
Unlike some other ubiquitin antibodies that require special membrane treatments, Ubi-1 works effectively with standard Western blot protocols, making it more convenient for routine applications.
Ubi-1 antibody can be used to study different ubiquitin chain linkage types, but researchers should be aware of its binding preferences. Experimental approaches include:
Comparative analysis using linkage-specific antibodies alongside Ubi-1
Using recombinant ubiquitin chains of defined linkage types (K48, K63, K11, etc.) as controls
Employing deubiquitinase treatment controls that selectively cleave specific linkage types
When troubleshooting Ubi-1 antibody use, researchers should consider:
High background issues:
Increase blocking time or blocking agent concentration
Optimize antibody dilution (try more dilute solutions)
Include additional wash steps
Ensure sample integrity by using fresh protease inhibitors
Weak or no signal:
Verify protein transfer efficiency
Check for protein degradation during sample preparation
Enrich ubiquitinated proteins prior to analysis
Confirm antibody integrity (avoid repeated freeze-thaw cycles)
Non-specific bands:
Include appropriate negative controls
Use more stringent washing conditions
Validate with alternative ubiquitin detection approaches
Ubi-1 antibody can enhance mass spectrometry-based ubiquitinome studies through:
Immunoprecipitation of ubiquitinated proteins prior to mass spectrometry analysis
Validation of mass spectrometry-identified ubiquitinated proteins using orthogonal Western blot detection
Enrichment of specific ubiquitinated protein populations before mass spectrometry
Confirmation of ubiquitination sites identified by mass spectrometry
The specificity of Ubi-1 for ubiquitinated cytoplasmic proteins makes it particularly useful for focusing analysis on this cellular compartment .
Rigorous experimental design with Ubi-1 should include these controls:
Positive controls:
Recombinant ubiquitin chains of known length and linkage type
Cell lysates treated with proteasome inhibitors to accumulate ubiquitinated proteins
Negative controls:
Isotype control antibodies (Mouse IgG1) to identify non-specific binding
Samples treated with deubiquitinating enzymes to remove ubiquitin modifications
Untreated versus treated samples when studying induced ubiquitination
Validation controls:
Parallel detection with alternative ubiquitin antibodies
Ubiquitin knockdown/knockout samples when available
Including the appropriate Mouse IgG1 isotype control (available as clones MOPC-21 or PPV-06) is particularly important for immunoprecipitation experiments to distinguish specific from non-specific binding .